Promethium Advisors’s Pfizer PFE Stock Holding History

Promethium Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Hold	81,378	–	–	0.94%	32
2026 Q1	$2.29M	Hold	81,378	–	–	1.18%	26
2025 Q4	$2.03M	Sell	81,378 -21,642	-21%	-$546K	1.09%	30
2025 Q3	$2.62M	Hold	103,020	–	–	1.51%	20
2025 Q2	$2.5M	Sell	103,020 -75	-0.1%	-$1.75K	1.52%	22
2025 Q1	$2.61M	Sell	103,095 -29,162	-22%	-$763K	1.67%	18
2024 Q4	$3.51M	Sell	132,257 -1,380	-1%	-$37.4K	2.4%	7
2024 Q3	$3.87M	Buy	+133,637	New	+$3.9M	2.73%	3

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Promethium Advisors's PFE Position: Q2 2026 in Review

Promethium Advisors held its Pfizer (PFE) position steady in Q2 2026 at 81,378 shares worth $1.96M. The position accounts for 0.94% of the portfolio, ranked #32.

Promethium Advisors first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.87M in Q3 2024. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Promethium Advisors held 81,378 shares of Pfizer worth $1.96M as of Q2 2026.
Promethium Advisors left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.94% of Promethium Advisors's portfolio in Q2 2026, its #32 holding.
Promethium Advisors first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
Promethium Advisors's Pfizer position peaked at $3.87M in Q3 2024.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Promethium Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.